Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Epigral Limited has informed the stock exchanges that its trading window will remain closed from Wednesday, 1st April 2026 until 48 hours after the declaration of the audited financial results for Q4 and the financial year ended 31st March 2026. During this period, all insiders, directors, promoters, designated persons, and their immediate relatives are prohibited from trading in the company's equity shares. The company has appointed CDSL to enforce this restriction by freezing PANs at the security level for its ISIN. The date of the board meeting to approve the Q4 and FY26 results will be announced separately.
This is a routine regulatory compliance announcement ahead of the upcoming quarterly results. It does not directly affect retail investors but signals that the company is preparing to release its Q4 and full-year FY26 audited results soon, which could be a catalyst for stock movement.